Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
2.370
+0.110 (4.87%)
At close: Nov 4, 2024, 4:00 PM
2.320
-0.050 (-2.11%)
After-hours: Nov 4, 2024, 6:03 PM EST
Mangoceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.87 | 0.73 | 0.01 | - |
| Revenue Growth (YoY) | 245.48% | 8083.16% | - | - |
| Cost of Revenue | 0.36 | 0.3 | 0 | - |
| Gross Profit | 0.5 | 0.43 | 0 | - |
| Selling, General & Admin | 6.66 | 6.39 | 2 | 0.07 |
| Operating Expenses | 9.03 | 8.55 | 2 | 0.07 |
| Operating Income | -8.53 | -8.12 | -1.99 | -0.07 |
| Interest Expense | -0.23 | - | -0.01 | -0 |
| Other Non Operating Income (Expenses) | -0.37 | -1.09 | - | - |
| Pretax Income | -9.13 | -9.21 | -2 | -0.07 |
| Net Income | -9.13 | -9.21 | -2 | -0.07 |
| Net Income to Common | -9.13 | -9.21 | -2 | -0.07 |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 |
| Shares Change (YoY) | 55.07% | 49.22% | 34.98% | - |
| EPS (Basic) | -6.47 | -8.58 | -2.78 | - |
| EPS (Diluted) | -6.47 | -8.58 | -2.78 | - |
| Free Cash Flow | -5.98 | -7 | -1.39 | -0.07 |
| Free Cash Flow Per Share | -4.24 | -6.52 | -1.93 | -0.13 |
| Gross Margin | 58.19% | 58.99% | 54.26% | - |
| Operating Margin | -983.76% | -1109.84% | -22279.70% | - |
| Profit Margin | -1052.86% | -1259.40% | -22352.11% | - |
| Free Cash Flow Margin | -689.54% | -957.07% | -15545.59% | - |
| EBITDA | -8.51 | -8.09 | -1.99 | - |
| D&A For EBITDA | 0.02 | 0.02 | 0 | - |
| EBIT | -8.53 | -8.12 | -1.99 | -0.07 |
Source: S&P Capital IQ. Standard template.
Financial Sources.